Ganga Pharmaceuticals IPO vs Navigant Corporate Advisors IPO

Comparison between Ganga Pharmaceuticals IPO and Navigant Corporate Advisors IPO.

IPO Details

Ganga Pharmaceuticals IPO is a SME Fixed Price IPO proposed to list at BSE SME while Navigant Corporate Advisors IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Ganga Pharmaceuticals IPO is up to ₹1.54 Cr whereas the issue size of the Navigant Corporate Advisors IPO is up to ₹1.12 Cr. The final issue price of Ganga Pharmaceuticals IPO is ₹15.00 per share and of Navigant Corporate Advisors IPO is ₹14.00 per share.

 Ganga Pharmaceuticals IPONavigant Corporate Advisors IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final)₹15.00 per share₹14.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)
Market Lot Size8000 shares10000 shares
Fresh Issue Size10,24,000 shares0 shares
Fresh Issue Size (Amount)up to ₹1.54 Crup to ₹0.00 Cr
OFS Issue Size0 shares8,00,000 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹1.12 Cr
Issue Size Total10,24,000 shares8,00,000 shares
Issue Size Total (Amount)up to ₹1.54 Crup to ₹1.12 Cr

IPO Timetable

Ganga Pharmaceuticals IPO opens on Jan 29, 2016, while Navigant Corporate Advisors IPO opens on Nov 30, 2015. The closing date of Ganga Pharmaceuticals IPO and Navigant Corporate Advisors IPO is Feb 09, 2016, and Dec 07, 2015, respectively.

Financials & KPIs

Ganga Pharmaceuticals IPO P/E ratio is , as compared to Navigant Corporate Advisors IPO P/E ratio of .

 Ganga Pharmaceuticals IPONavigant Corporate Advisors IPO
Financials

Company Financials ()

Period Ended
Amount in ₹ Crore

Company Financials ()

Period Ended
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)91.05100
Promoter Shareholding (Post-Issue)68.0973.04
P/E Ratio
Market Cap₹60.92 Cr.₹4.41 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW1.2719.8

Shares Offered

In the Ganga Pharmaceuticals IPO Retail Individual Investors (RII) are offered 5,12,000 shares while in Navigant Corporate Advisors IPO retail investors are offered 5,12,000 shares. Qualified Institutional Buyers (QIB) are offered in Ganga Pharmaceuticals IPO and in Navigant Corporate Advisors IPO.

 Ganga Pharmaceuticals IPONavigant Corporate Advisors IPO
Anchor Investor Reservation
Market Maker Reservation0 shares50,000 shares
QIB
NII5,12,000 shares4,00,000 shares
RII5,12,000 shares4,00,000 shares
Employee
Others
Total10,24,000 shares8,00,000 shares

Bids Received (Subscription)

Ganga Pharmaceuticals IPO subscribed 1.09x in total, whereas Navigant Corporate Advisors IPO subscribed 1.64x.

Compare with others

Compare:

Ganga Pharmaceuticals IPO Vs Navigant Corporate Advisors IPO